×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
LON:NIPT

Premaitha Health Share Forecast, Price & News

GBX 9.10
+0.20 (+2.25%)
(As of 11/6/2018)
Add
Compare
Today's Range
9.10
9.10
50-Day Range
9.10
9.10
52-Week Range
3.78
14.80
Volume
1.57 million shs
Average Volume
1.35 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Premaitha Health MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.22 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive NIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter.

Premaitha Health logo

About Premaitha Health (LON:NIPT) Stock

Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.

NIPT Stock News Headlines

Persimmon (LSE:PSN)
Premaitha Health Share Chat
(LSE:NIPT)
Recent Broker Ratings for Panmure Gordon
Who Owns Premaitha Health PLC (LON:NIPT)?
See More Headlines

Industry, Sector and Symbol

Industry
Medical Laboratories & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Company Calendar

Last Earnings
12/29/2017
Today
7/04/2022

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A














Premaitha Health Frequently Asked Questions

How has Premaitha Health's stock performed in 2022?

Premaitha Health's stock was trading at GBX 9.10 at the start of the year. Since then, NIPT stock has increased by 0.0% and is now trading at GBX 9.10.
View the best growth stocks for 2022 here
.

How were Premaitha Health's earnings last quarter?

Premaitha Health PLC (LON:NIPT) announced its quarterly earnings data on Friday, December, 29th. The company reported ($2.00) EPS for the quarter. The firm earned $2.71 million during the quarter.
View Premaitha Health's earnings history
.

Who are Premaitha Health's key executives?

Premaitha Health's management team includes the following people:
  • Dr. Stephen Little, Exec. Vice Chairman (Age 61)
  • Mr. Barry Hextall, CFO, Sec. & Exec. Director
  • Mr. Peter Collins, Chief Bus. Officer & Exec. Director (Age 59)
  • Mr. Lyn Fafydd Rees, CEO & Director (Age 45)
  • Dr. Chia-Han Chan, Chief Scientific Officer & Director (Age 42)

What other stocks do shareholders of Premaitha Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Scancell (SCLP), Sirius Minerals (SXX), Advanced Micro Devices (AMD) and Aviva (AV).

What is Premaitha Health's stock symbol?

Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."

How do I buy shares of Premaitha Health?

Shares of NIPT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Premaitha Health's stock price today?

One share of NIPT stock can currently be purchased for approximately GBX 9.10.

How can I contact Premaitha Health?

Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The official website for Premaitha Health is www.premaitha.com. The company can be reached via phone at +44-161-6676865.

This page (LON:NIPT) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.